GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Gross-Profit-to-Asset %

Devonian Health Group (TSXV:GSD) Gross-Profit-to-Asset % : 49.16% (As of Jul. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Devonian Health Group's annualized Gross Profit for the quarter that ended in Jul. 2024 was C$13.78 Mil. Devonian Health Group's average Total Assets over the quarter that ended in Jul. 2024 was C$28.04 Mil. Therefore, Devonian Health Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Jul. 2024 was 49.16%.

Devonian Health Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Devonian Health Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Gross-Profit-to-Asset % Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -1.54 3.10 4.38 24.00

Devonian Health Group Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 10.82 17.12 23.53 49.16

Competitive Comparison of Devonian Health Group's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Devonian Health Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Gross-Profit-to-Asset % falls into.


Devonian Health Group Gross-Profit-to-Asset % Calculation

Devonian Health Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jul. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jul. 2024 )/( (Total Assets (A: Jul. 2023 )+Total Assets (A: Jul. 2024 ))/ count )
=5.989/( (19.177+30.733)/ 2 )
=5.989/24.955
=24.00 %

Devonian Health Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Jul. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=13.784/( (25.345+30.733)/ 2 )
=13.784/28.039
=49.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jul. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Devonian Health Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
TSX:ATE TSX:MBX XCNQ:GLAB XCNQ:ACOG TSXV:TTI TSXV:MSCL TSX:TH TSX:HBP TSX:APS TSXV:CZO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
DVHGF:USA
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Website
https://www.groupedevonian.com
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines